Eintrag weiter verarbeiten
Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients
Gespeichert in:
Zeitschriftentitel: | Journal of International Medical Research |
---|---|
Personen und Körperschaften: | |
In: | Journal of International Medical Research, 15, 1987, 3, S. 128-133 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
SAGE Publications
|
Schlagwörter: |
author_facet |
Khan, A. U. Khan, A. U. |
---|---|
author |
Khan, A. U. |
spellingShingle |
Khan, A. U. Journal of International Medical Research Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients Biochemistry (medical) Cell Biology Biochemistry General Medicine |
author_sort |
khan, a. u. |
spelling |
Khan, A. U. 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/030006058701500302 <jats:p> Nineteen elderly hypertensive patients already being treated with a diuretic and, where necessary, another anti-hypertensive agent, were studied in a double-blind, randomized, crossover comparison of conventional propranolol, 40 mg three times daily, with a long-acting propranolol formulation, 160 mg once daily, as a second line agent. Patients were assessed before taking the morning's allocated medication. This was done as near as possible to 24 h after the last dose of once daily propranolol and as near as possible to 15 h after the last dose of three times daily conventional propranolol. Assessment was carried out at the time of randomization and after 4 weeks' treatment with both propranolol formulations. Heart rate and blood pressures were measured in the supine and standing positions and after exercise. Both propranolol formulations were effective as second line agents in these elderly patients and both were well tolerated. Patient compliance on both propranolol formulations was very good although the long-acting formulation may be of value in improving this still further. </jats:p> Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients Journal of International Medical Research |
doi_str_mv |
10.1177/030006058701500302 |
facet_avail |
Online |
finc_class_facet |
Biologie Chemie und Pharmazie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg3MDE1MDAzMDI |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg3MDE1MDAzMDI |
institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
imprint |
SAGE Publications, 1987 |
imprint_str_mv |
SAGE Publications, 1987 |
issn |
0300-0605 1473-2300 |
issn_str_mv |
0300-0605 1473-2300 |
language |
English |
mega_collection |
SAGE Publications (CrossRef) |
match_str |
khan1987comparisonofalongactingformofpropranololandconventionalpropranololinthetreatmentofhypertensioninelderlypatients |
publishDateSort |
1987 |
publisher |
SAGE Publications |
recordtype |
ai |
record_format |
ai |
series |
Journal of International Medical Research |
source_id |
49 |
title |
Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_unstemmed |
Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_full |
Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_fullStr |
Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_full_unstemmed |
Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_short |
Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_sort |
comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients |
topic |
Biochemistry (medical) Cell Biology Biochemistry General Medicine |
url |
http://dx.doi.org/10.1177/030006058701500302 |
publishDate |
1987 |
physical |
128-133 |
description |
<jats:p> Nineteen elderly hypertensive patients already being treated with a diuretic and, where necessary, another anti-hypertensive agent, were studied in a double-blind, randomized, crossover comparison of conventional propranolol, 40 mg three times daily, with a long-acting propranolol formulation, 160 mg once daily, as a second line agent. Patients were assessed before taking the morning's allocated medication. This was done as near as possible to 24 h after the last dose of once daily propranolol and as near as possible to 15 h after the last dose of three times daily conventional propranolol. Assessment was carried out at the time of randomization and after 4 weeks' treatment with both propranolol formulations. Heart rate and blood pressures were measured in the supine and standing positions and after exercise. Both propranolol formulations were effective as second line agents in these elderly patients and both were well tolerated. Patient compliance on both propranolol formulations was very good although the long-acting formulation may be of value in improving this still further. </jats:p> |
container_issue |
3 |
container_start_page |
128 |
container_title |
Journal of International Medical Research |
container_volume |
15 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792321241700368385 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T10:58:38.205Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Comparison+of+a+Long-Acting+Form+of+Propranolol+and+Conventional+Propranolol+in+the+Treatment+of+Hypertension+in+Elderly+Patients&rft.date=1987-05-01&genre=article&issn=1473-2300&volume=15&issue=3&spage=128&epage=133&pages=128-133&jtitle=Journal+of+International+Medical+Research&atitle=Comparison+of+a+Long-Acting+Form+of+Propranolol+and+Conventional+Propranolol+in+the+Treatment+of+Hypertension+in+Elderly+Patients&aulast=Khan&aufirst=A.+U.&rft_id=info%3Adoi%2F10.1177%2F030006058701500302&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792321241700368385 |
author | Khan, A. U. |
author_facet | Khan, A. U., Khan, A. U. |
author_sort | khan, a. u. |
container_issue | 3 |
container_start_page | 128 |
container_title | Journal of International Medical Research |
container_volume | 15 |
description | <jats:p> Nineteen elderly hypertensive patients already being treated with a diuretic and, where necessary, another anti-hypertensive agent, were studied in a double-blind, randomized, crossover comparison of conventional propranolol, 40 mg three times daily, with a long-acting propranolol formulation, 160 mg once daily, as a second line agent. Patients were assessed before taking the morning's allocated medication. This was done as near as possible to 24 h after the last dose of once daily propranolol and as near as possible to 15 h after the last dose of three times daily conventional propranolol. Assessment was carried out at the time of randomization and after 4 weeks' treatment with both propranolol formulations. Heart rate and blood pressures were measured in the supine and standing positions and after exercise. Both propranolol formulations were effective as second line agents in these elderly patients and both were well tolerated. Patient compliance on both propranolol formulations was very good although the long-acting formulation may be of value in improving this still further. </jats:p> |
doi_str_mv | 10.1177/030006058701500302 |
facet_avail | Online |
finc_class_facet | Biologie, Chemie und Pharmazie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTg3MDE1MDAzMDI |
imprint | SAGE Publications, 1987 |
imprint_str_mv | SAGE Publications, 1987 |
institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
issn | 0300-0605, 1473-2300 |
issn_str_mv | 0300-0605, 1473-2300 |
language | English |
last_indexed | 2024-03-01T10:58:38.205Z |
match_str | khan1987comparisonofalongactingformofpropranololandconventionalpropranololinthetreatmentofhypertensioninelderlypatients |
mega_collection | SAGE Publications (CrossRef) |
physical | 128-133 |
publishDate | 1987 |
publishDateSort | 1987 |
publisher | SAGE Publications |
record_format | ai |
recordtype | ai |
series | Journal of International Medical Research |
source_id | 49 |
spelling | Khan, A. U. 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/030006058701500302 <jats:p> Nineteen elderly hypertensive patients already being treated with a diuretic and, where necessary, another anti-hypertensive agent, were studied in a double-blind, randomized, crossover comparison of conventional propranolol, 40 mg three times daily, with a long-acting propranolol formulation, 160 mg once daily, as a second line agent. Patients were assessed before taking the morning's allocated medication. This was done as near as possible to 24 h after the last dose of once daily propranolol and as near as possible to 15 h after the last dose of three times daily conventional propranolol. Assessment was carried out at the time of randomization and after 4 weeks' treatment with both propranolol formulations. Heart rate and blood pressures were measured in the supine and standing positions and after exercise. Both propranolol formulations were effective as second line agents in these elderly patients and both were well tolerated. Patient compliance on both propranolol formulations was very good although the long-acting formulation may be of value in improving this still further. </jats:p> Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients Journal of International Medical Research |
spellingShingle | Khan, A. U., Journal of International Medical Research, Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients, Biochemistry (medical), Cell Biology, Biochemistry, General Medicine |
title | Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_full | Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_fullStr | Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_full_unstemmed | Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_short | Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
title_sort | comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients |
title_unstemmed | Comparison of a Long-Acting Form of Propranolol and Conventional Propranolol in the Treatment of Hypertension in Elderly Patients |
topic | Biochemistry (medical), Cell Biology, Biochemistry, General Medicine |
url | http://dx.doi.org/10.1177/030006058701500302 |